RELATION OF PULMONARY LYMPHANGIOLEIOMYOMATOSIS TO USE OF THE ORAL-CONTRACEPTIVE PILL AND FERTILITY IN THE UK - A NATIONAL CASE-CONTROL STUDY

被引:38
|
作者
WAHEDNA, I
COOPER, S
WILLIAMS, J
PATERSON, IC
BRITTON, JR
TATTERSFIELD, AE
机构
[1] CITY HOSP NOTTINGHAM,DIV RESP MED,NOTTINGHAM NG5 1PB,ENGLAND
[2] CTY HOSP,LINCOLN LN2 5QY,ENGLAND
关键词
D O I
10.1136/thx.49.9.910
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background - Pulmonary lymphangioleiomyomatosis is a rare progressive disease of unknown aetiology affecting premenopausal women. Since the oral contraceptive pill has been implicated in its pathogenesis, a case control study was carried out to determine whether women with the disease were more likely to have taken the oral contraceptive pill, and whether the disease was associated with other conditions related to sex hormones including pregnancy, parity, and fibroids. Methods - All chest physicians in the UK were asked for details of all live patients with pulmonary lymphangioleiomyomatosis; the patient's family doctor was then asked for four age and sex matched control subjects from their patient register. Details of lifetime use of the oral contraceptive pill, pregnancy, parity, history of fibroids, and smoking were obtained from cases and controls. Relative odds of exposure to potential risk factors were estimated by conditional logistic regression. Results - Medical details were obtained from all 23 cases of lymphangioleiomyomatosis identified; questionnaires were completed by 21 cases (one by proxy) and by 46 matched controls of mean (SD) age 43 (10) and 44 (11) years, respectively. The patients had a mean age of 34 (9) years at onset of symptoms and a median (range) time of 2 (0-29) years from onset of symptoms to diagnosis. Compared with control subjects, cases did not differ in the use of the oral contraceptive pill (odds ratio (OR) 0.39, 95% CI 0.09 to 1.68), diagnosis of fibroids (OR 3.12; 95% CI 0.52 to 18.7), age of menarche, menstrual history, or lifetime smoking. They were, however, less likely to have been pregnant (OR 0.14, 95% CI 0.03 to 0.71) or to have had children (OR 0.13, 95% CI 0.03 to 0.67). More pregnancies had ended in spontaneous abortion (28% v 8%) but the proportion of women undergoing spontaneous abortion was similar in cases and controls (OR 2.13, 95% CI 0.47 to 9.3). Conclusions - This study does not support the hypothesis that use of the oral contraceptive pill is causally associated with the development of pulmonary lymphangioleiomyomatosis. Sex hormones may be involved, however, since patients were less likely to have been pregnant or to have had children, and tended to have had more spontaneous abortions and an increased incidence of fibroids.
引用
收藏
页码:910 / 914
页数:5
相关论文
共 50 条
  • [1] A CASE-CONTROL STUDY OF BREAST-CANCER IN RELATION TO ORAL-CONTRACEPTIVE USE IN SLOVENIA
    RAVNIHAR, B
    ZAKELJ, MP
    KOSMELJ, K
    STARE, J
    NEOPLASMA, 1988, 35 (01) : 109 - 121
  • [2] A CASE-CONTROL STUDY OF THE RISK OF BREAST-CANCER IN RELATION TO ORAL-CONTRACEPTIVE USE
    ROSENBERG, L
    PALMER, JR
    CLARKE, EA
    SHAPIRO, S
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1992, 136 (12) : 1437 - 1444
  • [3] Oral-contraceptive use and risk of hip fracture:: a case-control study
    Michaëlsson, K
    Baron, JA
    Farahmand, BY
    Persson, I
    Ljunghall, S
    LANCET, 1999, 353 (9163): : 1481 - 1484
  • [4] RETROSPECTIVE CASE-CONTROL STUDY OF DISEASES ASSOCIATED WITH ORAL-CONTRACEPTIVE USE
    GREENBLATT, DJ
    AMERICAN HEART JOURNAL, 1975, 89 (05) : 677 - 678
  • [5] A CASE-CONTROL STUDY OF ORAL-CONTRACEPTIVE USE IN WOMEN WITH ADENOCARCINOMA OF THE UTERINE CERVIX
    PERSSON, E
    EINHORN, N
    PETTERSSON, F
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1987, 26 (01): : 85 - 90
  • [6] CASE-CONTROL STUDY OF ORAL-CONTRACEPTIVE PILLS AND ENDOMETRIAL CANCER
    HORWITZ, RI
    FEINSTEIN, AR
    ANNALS OF INTERNAL MEDICINE, 1979, 91 (02) : 226 - 227
  • [7] A CASE-CONTROL STUDY OF ORAL-CONTRACEPTIVE USE AND INVASIVE EPITHELIAL OVARIAN-CANCER
    ROSENBERG, L
    PALMER, JR
    ZAUBER, AG
    WARSHAUER, ME
    LEWIS, JL
    STROM, BL
    HARLAP, S
    SHAPIRO, S
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1994, 139 (07) : 654 - 661
  • [8] ORAL-CONTRACEPTIVE USE AND RISK OF MYOCARDIAL-INFARCTION - AN ITALIAN CASE-CONTROL STUDY
    DAVANZO, B
    LAVECCHIA, C
    NEGRI, E
    PARAZZINI, F
    FRANCESCHI, S
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 1994, 48 (03) : 324 - 325
  • [9] ORAL-CONTRACEPTIVE USE AND THE RISK OF OVARIAN-CANCER - AN ITALIAN CASE-CONTROL STUDY
    PARAZZINI, F
    LAVECCHIA, C
    NEGRI, E
    BOCCIOLONE, L
    FEDELE, L
    FRANCESCHI, S
    EUROPEAN JOURNAL OF CANCER, 1991, 27 (05) : 594 - 598
  • [10] A CASE-CONTROL STUDY OF THE ASSOCIATION BETWEEN ORAL-CONTRACEPTIVE USE AND BREAST-CANCER
    CHEN, CJ
    ANTICANCER RESEARCH, 1986, 6 (03) : 370 - 370